Cytologic-Histologic Correlation Practices for Nongynecologic Cytology Specimens A Survey by the College of American Pathologists Cytopathology Committee

被引:0
|
作者
Nguyen, Lananh N. [1 ]
Crothers, Barbara A. [2 ]
Souers, Rhona J. [3 ]
Barkan, Guliz A. [4 ]
Brainard, Jennifer [5 ]
Nassar, Aziza [6 ]
Rollins, Susan [7 ]
Tabatabai, Z. Laura [8 ,9 ]
Tabbara, Sana
Witt, Benjamin [10 ]
Booth, Christine N. [5 ]
机构
[1] Univ Toronto, Dept Lab Med & Pathobiol, 30 Bond St, Toronto, ON M5B1W8, Canada
[2] Joint Pathol Ctr, Gynecol Breast & Cytopathol, Silver Spring, MD USA
[3] Coll Amer Pathologists, Biostat Dept, Northfield, IL USA
[4] Loyola Univ Healthcare Syst, Dept Pathol & Lab Med, Maywood, IL USA
[5] Cleveland Clin, Dept Anat Pathol, Cleveland, OH USA
[6] Mayo Clin, Dept Lab Med & Pathol, Jacksonville, FL USA
[7] Outpatient Cytopathol Ctr, Johnson City, TN USA
[8] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA
[9] H Lee Moffitt Canc Ctr & Res Inst, Pathol Dept, Tampa, FL USA
[10] Univ Utah, Dept Pathol, ARUP Labs, Salt Lake City, UT USA
关键词
PATIENT SAFETY;
D O I
10.5858/arpa.2023-0140-CP
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
center dot Context.-Cytologic-histologic correlation (CHC) is a Clinical Laboratory Improvement Amendments-mandated requirement for gynecologic cytology, but no similar requirement exists for nongynecologic cytology. This study presents the findings from a College of American Pathologists survey of nongynecologic cytology practice patterns. Objective.-To survey the current CHC practices for nongynecologic cytology. Design.-Data were analyzed from a survey developed by the committee and distributed to participants in the Nongynecologic Cytopathology Education Program mailing. Results.-Adoption of CHC for nongynecologic cytology cases is worldwide, with 88.5% of institutions performing CHC on these specimens, a substantial increase from previous years. Performance of CHC varied by institution type, with clinic or regional/local independent laboratories and national/corporate laboratories performing CHC significantly less frequently than hospitals, university hospitals/academic medical centers, and Veterans Administration/Department of Defense hospital institutions. Most CHC was performed concurrently in real time, when the corresponding surgical specimen was reviewed. Selection for real-time concurrent CHC was by the interpreting pathologist, the pathologist diagnosing the surgical biopsy sample or cytopathology case, or both. Sampling was by far the most common reason for dis- cordance. A 2-step difference was the most frequent threshold for discordance between cytology and surgical specimens, but this criterion varied among institutions, with no majority definition. The positive predictive value of a positive cytology finding was calculated rarely in North American institutions but was calculated more frequently in international institutions. Conclusions.-CHC CHC practices for nongynecologic cytopa- thology mirror those found for CHC of gynecologic cyto- pathology.
引用
收藏
页码:871 / 879
页数:9
相关论文
共 50 条